Detalhe da pesquisa
1.
Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach.
Eur J Med Chem
; 260: 115713, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37597437